TDC
NEO icon

Thompson Davis & Co’s NeoGenomics NEO Stock Holding History

Thompson Davis & Co’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-10,000
Closed -$57K – 1170
2015
Q3 		$57K Buy
+10,000
New +$61.9K 0.08% 239
2014
Q2 		– Sell
-15,800
Closed -$55K – 819
2014
Q1 		$55K Buy
+15,800
New +$59.2K 0.09% 234

Other funds holding NEO

GE
General Electric Evendale, Ohio $308M AUM 40.86% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KIA
Kopp Investment Advisors Bloomington, Minnesota $54.4M AUM 14.33% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
RFC
Russell Frank Company Seattle, Washington $56.9B AUM 2.13% 1-Year Est. Return

Thompson Davis & Co's NEO Position: Q4 2015 in Review

Thompson Davis & Co sold out of NeoGenomics (NEO) in Q4 2015, closing a stake of 10,000 shares — an estimated $57K sold.

Thompson Davis & Co first reported a position in NEO in Q1 2014 and held it in 2 quarters. The position peaked at $57K in Q3 2015. 119 funds tracked by Wall St. Rank hold NEO as of Q4 2015.

  • Thompson Davis & Co reported no remaining NeoGenomics position as of Q4 2015 after selling out during the quarter.
  • Thompson Davis & Co sold 10,000 NeoGenomics shares in Q4 2015, an estimated $57K.
  • Thompson Davis & Co first reported a position in NeoGenomics in Q1 2014 and held it in 2 quarters.
  • Thompson Davis & Co's NeoGenomics position peaked at $57K in Q3 2015.
  • 119 funds tracked by Wall St. Rank held NeoGenomics as of Q4 2015.

Based on Thompson Davis & Co's 13F filing for Q4 2015, filed 1 Feb 2016.